NVAX - Novavax seeks FDA authorization for updated JN.1 COVID shot
2024-06-14 15:22:07 ET
More on Novavax
- Novavax: Sanofi Partnership Revitalizes My Magnum Opus
- FDA recommends KP.2 strain be used in updated COVID-19 shots
- FDA selects JN.1 variant for next COVID vaccine campaign
- Novavax, Inc. (NVAX) Jefferies 2024 Global Healthcare Conference (Transcript)
- Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript